This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.
Novosanis will be present at the Brazilian Clinical Pathology Conference from September 25 to 28, 2018 in Brazil where we will launch our Colli-Pee device for the Brazilian market. Do come...
Novosanis will be present at the Brazilian Clinical Pathology Conference from September 25 to 28, 2018 in Brazil where we will launch our Colli-Pee device for the Brazilian market. Do come...
Being ISO13485 is all about continuous improvement and learning. Novosanis is attending RAPS Convergence in Vancouver, Canada to gain more insights in regulatory approvals all over the...
Novosanis is attending the IPVC 2018 conference in Sydney, Australia from October 2 to October 6, 2018. Excited to present our latest results on the Colli-Pee device suited for (home-based...
We love partnering events, great way to meet new people and catch-up with existing contacts. Novosanis will be attending BioJapan in Yokohama from October 10 to 12, 2018 as part of the...
Novosanis will attend the 28th European Congress of Clinical Microbiology and Infectious Diseases, which will take place in Madrid, Spain, from 21 - 24 April 2018 . Check out our poster on...
Novosanis will be attending AACC in Chicago, US from July 30 to Agust 2, 2018. Our Sales & Business Development Director LATAM & US, Jeane Brunmark is excited to meet you and...
Organized by Vaccine, the premier journal for those interested in vaccine science, the 12th Vaccine Congress 2018 will bring together leading experts from all over the world to share the...
Novosanis
